6.3 Dengue Fever, Arboviral Infections & Leptospirosis

Arboviral Epidemiology & Vector Biology in the Caribbean

Vector-borne arboviral diseases represent recurrent, seasonal epidemics throughout the Caribbean basin, driven by tropical climate patterns, urbanization, and the widespread domestic proliferation of the primary vector, Aedes aegypti (and to a lesser extent, Aedes albopictus). These container-breeding mosquitoes bite predominantly during daylight hours (early morning and late afternoon).

• Dengue Virus (DENV): A positive-sense single-stranded RNA virus of the family Flaviviridae, comprising four distinct antigenic serotypes (DENV-1, DENV-2, DENV-3, DENV-4). Infection with one serotype confers lifelong homotypic immunity to that specific serotype, but only transient cross-protection (lasting a few months) against heterologous serotypes.
• Antibody-Dependent Enhancement (ADE): When an individual previously infected with one serotype experiences a secondary infection with a different heterologous serotype, pre-existing sub-neutralizing non-protective antibodies bind to the new virions. These antibody-virus complexes facilitate viral entry into monocytes and macrophages via surface Fc-gamma receptors. This produces amplified intracellular viral replication, massive activation of cross-reactive T-cells, and an intense 'cytokine storm' (interleukins IL-6, IL-8, IL-10, TNF-alpha, and VEGF). This inflammatory surge disrupts endothelial glycocalyx integrity, causing acute microvascular hyperpermeability and plasma leakage, which can cause shock or respiratory distress in severe dengue.

---

Triphasic Clinical Course of Dengue

Dengue is a dynamic illness characterized by three distinct phases: febrile, critical, and recovery.

1. Febrile Phase (Usually 2 to 7 Days)

• Presentation: Sudden onset of high continuous fever (39°C to 40°C), accompanied by severe retro-orbital headache, photophobia, intense generalized arthralgia and myalgia (hence the historical designation 'breakbone fever'), facial flushing, anorexia, and nausea.
• Physical Signs: Generalized erythema or a fine macular rash; positive tourniquet test (standard blood pressure cuff inflated midway between systolic and diastolic BP for 5 minutes; $\ge 10$ petechiae per square inch confirms capillary fragility).
• Laboratory Findings: Progressive leukopenia (WBC often $< 4.0 \times 10^9/\text{L}$), mild thrombocytopenia, and normal hematocrit.

2. Critical Phase (Days 3 to 7, Around Defervescence)

• Onset: Coincides with the transition when fever rapidly subsides to normal or subnormal levels (37.5°C to 38.0°C). Many clinicians mistakenly assume defervescence heralds clinical recovery, whereas it marks the window of highest vulnerability to life-threatening plasma leakage lasting 24 to 48 hours.
• Pathophysiology: Sudden endothelial hyperpermeability causes plasma extravasation from the intravascular space into serous cavities (pleural spaces, peritoneum, pericardium).
• Laboratory Hallmark: Hemoconcentration (hematocrit increases by $\ge 20\%$ above baseline) occurring concurrently with a rapid, precipitous drop in platelet count (often $< 100 \times 10^9/\text{L}$ or $< 50 \times 10^9/\text{L}$).
• Warning Signs (WHO 2009 Criteria):
  • Severe abdominal pain or tenderness (secondary to gallbladder wall edema or mesenteric ischemia)
  • Persistent vomiting or inability to tolerate oral fluids
  • Clinical fluid accumulation (pleural effusion on CXR/ultrasound, ascites)
  • Mucosal bleeding (epistaxis, gingival bleeding, hematemesis, melena, heavy menorrhagia)
  • Lethargy, restlessness, or altered mental status
  • Hepatomegaly > 2 cm below the right costal margin
  • Laboratory: Rapid rise in hematocrit concurrent with rapid fall in platelet count

3. Recovery (Convalescent) Phase (Days 7 to 10)

• Extravasated fluid is gradually reabsorbed from serous spaces back into the intravascular compartment over 48 to 72 hours.
• General well-being improves, appetite returns, gastrointestinal symptoms abate, and hemodynamic status stabilizes with brisk spontaneous diuresis.
• Convalescent Rash: An erythematous, confluent morbilliform rash with distinct spared areas of pale, normal skin—classically termed 'islands of white in a sea of red'—associated with intense generalized pruritus, particularly on the palms and soles.
• Physiological sinus bradycardia is common.
• Iatrogenic Hazard: Continuing aggressive intravenous fluids during this reabsorption phase causes lethal pulmonary edema and fluid overload.

---

2009 WHO Classification of Dengue

---

Management Protocols & Clinical Pitfalls in Dengue

• Absolute Contraindications:
  • Strictly avoid NSAIDs, Aspirin, and Corticosteroids: NSAIDs (ibuprofen, diclofenac, naproxen) and aspirin cause platelet cyclooxygenase-1 inhibition and gastritis, precipitating catastrophic gastrointestinal hemorrhage in thrombocytopenic patients. Corticosteroids provide no mortality benefit and increase bacterial superinfection risk.
  • Strictly avoid Intramuscular (IM) Injections: High risk of large, painful intramuscular hematomas in coagulopathic/thrombocytopenic patients.
  • Antipyresis: Prescribe Paracetamol only (maximum 3 g/day in adults; 10–15 mg/kg/dose 6-hourly in children) to avoid hepatotoxicity.
• Fluid Titration for Dengue With Warning Signs:
  • Obtain baseline hematocrit before initiating IV fluids.
  • Administer isotonic crystalloid (0.9% Normal Saline or Hartmann's / Ringer's Lactate) at 5 to 7 mL/kg/hour for 1 to 2 hours.
  • If clinical parameters and urine output improve, taper to 3 to 5 mL/kg/hour for 2 to 4 hours, then reduce to 2 to 3 mL/kg/hour for 2 to 4 hours.
  • Titrate dynamically against hourly urine output (maintain > 0.5 mL/kg/hour) and serial hematocrit checks every 4 to 6 hours.
  • Total IV fluid duration should rarely exceed 24 to 48 hours.
• Resuscitation of Dengue Shock Syndrome (DSS):
  • Compensated shock: start isotonic crystalloid 5–10 mL/kg over 1 hour. Hypotensive shock: give 20 mL/kg over 15 minutes, reassessing perfusion frequently and adjusting for comorbidities.
  • When circulation improves, reduce fluids progressively; do not give shock boluses solely for organ involvement without hypoperfusion.
  • Persistent shock needs urgent reassessment of perfusion, hematocrit, fluid responsiveness and bleeding. Further crystalloids are preferred; specialist-directed colloid rescue may be considered after inadequate response to repeated crystalloid boluses.
  • If the hematocrit drops precipitously without clinical hemodynamic recovery, suspect occult internal hemorrhage and transfuse crossmatched packed red blood cells immediately.

---

Chikungunya & Zika Viruses: Clinical Differentiation

During regional arboviral epidemics, clinicians must distinguish Dengue from Chikungunya and Zika:

• Chikungunya Virus (Togaviridae, Alphavirus):
  • Characterized by abrupt high fever, maculopapular rash, and severe, disabling, symmetric polyarthralgia and tenosynovitis primarily targeting the wrists, small joints of hands, ankles, and knees.
  • The word Chikungunya is derived from the Makonde language meaning 'that which bends up', describing the stooped posture assumed by sufferers due to excruciating articular pain.
  • While dengue causes diffuse muscle ache ('breakbone' myalgia), chikungunya produces frank inflammatory joint swelling, effusion, and severe morning stiffness.
  • Persistent Chikungunya Joint Symptoms: Arthralgia or arthritis can persist for months or years. Manage pain and disability with analgesia, NSAIDs once dengue is excluded, and physiotherapy. Persistent inflammatory arthritis warrants rheumatology assessment; selected patients may need DMARDs such as methotrexate.
• Zika Virus (Flaviviridae):
  • Approximately 80% of infections are asymptomatic; symptomatic illness is usually mild and self-limiting, characterized by low-grade fever, pruritic descending maculopapular rash, mild arthralgia, and bilateral non-purulent conjunctivitis.
  • Major Complications:
    • Guillain-Barré Syndrome (GBS): Acute post-infectious autoimmune polyradiculoneuropathy presenting with ascending symmetric flaccid paralysis and areflexia in adults.
    • Congenital Zika Syndrome: Maternal infection during pregnancy results in viral neurotropism destroying fetal neural progenitor cells, causing severe fetal microcephaly, craniofacial disproportion, intracranial cerebral calcifications, ventriculomegaly, macular chorioretinal atrophy, and arthrogryposis.
    • Can be sexually transmitted via semen; barrier contraception is recommended following travel to endemic areas.

---

Leptospirosis (Leptospira interrogans) & Weil's Disease

Leptospirosis is a widespread bacterial zoonosis caused by pathogenic spirochetes of the genus Leptospira. It is endemic across the Caribbean, where transmission peaks sharply following tropical storms, hurricanes, and heavy rainfall that induce environmental flooding.

Transmission & Pathogenesis

• Reservoir hosts (particularly brown rats, Rattus norvegicus, as well as livestock and dogs) harbor spirochetes chronologically within their renal tubules, shedding high concentrations into urine.
• Humans contract infection through direct mucosal contact or percutaneous penetration of broken skin (cuts, abrasions) exposed to water, mud, or soil contaminated with infected rodent urine (agricultural workers, sugarcane harvesters, sewer workers, or flood victims).

Clinical Presentation: Biphasic Illness

1. Septicemic (Leptospiremic) Phase (Days 1 to 7): Abrupt high fever, rigors, headache, retro-orbital pain, severe abdominal pain, and intense calf and lumbar myalgia.
2. Pathognomonic Physical Sign: Conjunctival suffusion without purulence (bilateral dilatation of conjunctival episcleral vessels without inflammatory exudate or pus). Present in ~50% of cases within the first 48 hours; highly specific when paired with severe calf tenderness.
3. Immune Phase (Days 8+): Disappearance of spirochetes from blood and emergence of circulating IgM antibodies; can manifest as aseptic meningitis, uveitis, or progression to severe multi-organ dysfunction.

Severe Leptospirosis: Weil's Disease (Icteric Form)

Weil's disease occurs in 5% to 10% of patients and carries a mortality of 15% to 40%.

• The Classic Triad of Weil's Disease:
  1. Profound Jaundice: Bright reddish-orange ('rubinic') jaundice caused by extensive hepatic sinusoidal capillaritis and intrahepatic cholestasis. Conjugated hyperbilirubinemia is markedly disproportionate to transaminase elevations (AST and ALT are typically only mildly elevated, < 200–500 U/L, distinguishing it from viral hepatitis where transaminases exceed 1000 U/L).
  2. Acute Kidney Injury (AKI): Direct tubular toxicity and interstitial nephritis. A unique hallmark of early leptospiral nephropathy is an isolated impairment of sodium and potassium reabsorption in the proximal tubule and thick ascending limb, leading to polyuria and profound hypokalemia before progressing to oliguric azotemic renal failure.
  3. Hemorrhagic Diathesis: Diffuse endothelial vasculitis causing widespread petechiae, purpura, epistaxis, and lethal severe pulmonary hemorrhage syndrome (SPHS). SPHS presents with acute breathlessness, hemoptysis, and bilateral alveolar infiltrates on CXR, representing the leading cause of death in severe leptospirosis.

Diagnostic Evaluation & Pharmacotherapy

• Diagnostics: Microscopic Agglutination Test (MAT, the definitive reference serology showing $\ge 4$-fold rise in titer), IgM ELISA, and real-time PCR in blood (first 7 days) or urine (after day 7).
• Pharmacotherapy:
  • Mild Outpatient Leptospirosis: Oral Doxycycline 100 mg BD for 7 days (or oral Azithromycin 500 mg daily).
  • Severe Leptospirosis / Weil's Disease: Intravenous Penicillin G 1.5 million units IV every 6 hours for 7 days; or intravenous Ceftriaxone 1 g to 2 g IV daily for 7 days.
  • Jarisch-Herxheimer Reaction: Clinicians must monitor patients closely during the first 2 to 12 hours after initiating penicillin or ceftriaxone. Rapid spirochete lysis releases inflammatory endotoxins, triggering acute fever, rigors, tachycardia, and peripheral vasodilatory hypotension. Manage with IV crystalloid resuscitation and supportive antipyresis.

---

Differential Comparison: Dengue vs. Leptospirosis vs. Chikungunya